Antibody Therapeutics for Life

Notices

PharmAbcine was introduced today in The South China Morning Post-2018 South Korea Business Report.
  • Written by Admin
  • Written date 2019-01-14 11:32:43
  • Inquire 1126

PharmAbcine was introduced today in The South China Morning Post-2018 South Korea Business Report.

 

Please see the attached file for more information.

List





Prev PharmAbcine enters collaboration with MSD focused on clinical evaluation of TTAC...
Next Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited ...